trans-4-n-Propylcyclohexanecarboxylic acid; >99%, 98.0%, 10g

N-[(9R)-6′-Methoxycinchonan-9-yl]-8-quinolinesulfonamide, 100mg

Potassium clavulanate (40%) : silicon dioxide mixture, 95.0%, 25g

[(3,4-dimethoxyphenyl)methyl](propyl)amine, 95.0%, 10g

Hydroxylamine-O-sulfonic Acid>90.0%(T)500g

Ethyl-(1-methyl-piperidin-3-yl)-amine, 95.0%, 500mg

(1S,2S)-N1,N1,N2,N2-Tetramethyl-1,2-diphenylethane-1,2-diamine, 97.0%, 1g

Manganese(II) chloride tetrahydrate, min. 99%, pa, 1 kg, plastic packaging.

1,3-Dibutylthiourea>97.0%(N)25g

Ethyl 2-(3-chlorophenyl)oxazole-4-carboxylate, 98%, 250mg

(R)-1-Amino-indan-4-ol hydrochloride, 96%, 50mg

N-(4-Nitrophenyl)-4-(3-pyridyl)-2-pyrimidineamine, 98%, 250mg

Heptafluorobutyramide, 97.0%, 1g